malondialdehyde has been researched along with insulin glargine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bunck, MC; Cornér, A; Diamant, M; Eliasson, B; Heine, RJ; Shaginian, RM; Smith, U; Taskinen, MR; Wu, Y; Yan, P; Yki-Järvinen, H | 1 |
| Ali, RH; Ali, SK | 1 |
1 trial(s) available for malondialdehyde and insulin glargine
| Article | Year |
|---|---|
One-year treatment with exenatide vs. insulin glargine: effects on postprandial glycemia, lipid profiles, and oxidative stress.
Topics: Apolipoprotein B-48; Biomarkers; Blood Glucose; Cholesterol, VLDL; Diabetes Mellitus, Type 2; Drug Administration Schedule; Europe; Exenatide; Fatty Acids, Nonesterified; Female; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Lipids; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Peptides; Postprandial Period; Time Factors; Treatment Outcome; Triglycerides; Venoms | 2010 |
1 other study(ies) available for malondialdehyde and insulin glargine
| Article | Year |
|---|---|
Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Biomarkers; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Donepezil; Glucose; Glyburide; Glycated Hemoglobin; Hypoglycemic Agents; Insulin Glargine; Male; Malondialdehyde; Metformin; Microtubule-Associated Proteins; Nitric Oxide; Rats; Rats, Wistar; Streptozocin; Triglycerides; Tumor Necrosis Factor-alpha | 2022 |